Prominent German Financial Institution Enters Cannabis Industry
Germany’s emerging legal cannabis industry continues to go mainstream, with the latest example of that coming in the form of cannabis company GOC Nexus receiving funding from leading German financial institution Volksbank Donau-Mindel.
Volksbank Donau-Mindel was joined in the successful funding round by a concurrent investment from Synbiotic, Germany’s largest publicly listed cannabis company, and was coordinated by leading European cannabis investment firm The Talman House. Synbiotic is a member of The Talman House.
Volksbank Donau-Mindel and Synbiotic’s funding of GOC Nexus, a cutting-edge cannabis technology company that is revolutionizing the processing of medicinal and recreational cannabis, will create the first production facility of its kind that is compliant with EU-GMP standards.
“Despite significant interest from potential business partners in our services, particularly the microbiological cold plasma treatment of cannabis flowers, many were reluctant to invest upfront.” Stated Dr. David Surjo, CEO of GOC Nexus.
“The initial investments required for a pharmaceutical production facility are substantial, making it impossible to finance entirely from internal resources.” Dr. Surjo said. “After deciding to approach banks, we concentrated on local banks without a presence in the USA or Canada. This was crucial, as international banks often face legal restrictions when dealing with cannabis businesses.”
“We are excited that the cooperative bank Volksbank Donau-Mindel supports our project. Their interest in innovative business models and flexibility were key to our success.” Dr. Surjo also stated.
The significance of this successful funding round cannot be overstated. It is no secret that the legal cannabis industry has struggled to gain consistent access to the world’s banking system, and gaining funding from prominent financial institutions has proven to be particularly difficult for cannabis companies. From that perspective, Volksbank Donau-Mindel’s investment is a very big deal, and a testament to the benefits of cannabis companies becoming members of The Talman House network.
The Talman House is private and exclusive, with dozens of leading cannabis companies already serving as members. It is the largest private network of cannabis investors and executives in Europe and has helped established cannabis companies secure funding, including GOC Nexus.
GOC Nexus’ innovative cold plasma technology designed by an experienced multidisciplinary team, is revolutionizing the cannabis industry through its unique combination of efficiency, product safety, and the preservation of therapeutically valuable compounds.
The company’s patent-pending process combines optimal cleaning performance with careful, gentle treatment. This is achieved through minimal energy input and synergistic cleaning effects of activated plasma particles. Cold plasma processing sets new standards compared to conventional methods. The treatment enhances the product by safely eliminating microbiology while preserving the entourage effect of cannabinoids.
GOC Nexus technology protects the organoleptic properties of the processed material. The terpene profile, essential for the therapeutic entourage effect, remains completely intact. Traditional methods destroy 30-70% of volatile active compounds and destabilize cannabinoids. The trichomes, as production sites of cannabinoids and terpenes, remain undamaged through the gentle cold plasma treatment. This ensures taste, aroma, therapeutic efficacy, and pharmaceutical stability. The optical quality of the flowers is also preserved, increasing patient acceptance.
It is estimated that today more than 50% of cannabis produced worldwide does not meet microbiological requirements. GOC-NEXUS helps cultivators control the microbiological contamination of the final product through a non-thermal, non-radiative remediation service without using any chemical agents.
